Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles

Scientists Reaching Consensus On How Brain Processes Speech
Neuroscientists feel they are much closer to an accepted unified theory about how the brain processes speech and language, according to a scientist at Georgetown University Medical Center who first laid the concepts a decade ago and who has now published a review article confirming the theory.

Nurses To Stage Massive Protest At County Vote To Save San Leandro Hospital - Tuesday
Registered nurses, healthcare workers and community leaders will hold a major protest rally Tuesday at noon, outside of the Alameda County Administration building. The action, one of many occurring over the last two months, is being held on the day that the board is scheduled to vote on Sutter Health"s plan to rebuild Eden Medical Center in Castro Valley as a luxury hospital with all private rooms and 48 fewer beds. It is likely that approval will result in closure of the 122-bed San Leandro Hospital, also owned and operated by Sutter.
News of the day
DOR BioPharma Announces Publication Of OrBec(R) Clinical Pulmonary Data In Bone Marrow Transplantation
DOR BioPharma, Inc. (DOR or the Company) (OTC Bulletin Board: DORB), a late-stage biopharmaceutical company, announced that investigators at the Fred Hutchinson Cancer Research Center, Seattle, Washington, published a paper this morning in Bone Marrow Transplantation in which they demonstrate that DOR"s lead product orBec(R) (oral beclomethasone dipropionate or BDP) decreases non-infectious inflammation of the lung in acute gastrointestinal Graft-versus-Host disease (GI GVHD) patients who received allogeneic hematopoietic cell transplants (HCT). Non-infectious inflammation of the lung is a common and potentially fatal complication of HCT that decreases the exchange of oxygen and carbon dioxide between the lung and blood and, in its severe form, may present as interstitial pneumonitis. The full article, entitled "Influence of Oral Beclomethasone Dipropionate on Early Non-Infectious Pulmonary Outcomes after Allogeneic Hematopoietic Cell Transplantation.
Sexual Health

Roche Launches New PCR Assay For Tuberculosis Testing In South Africa

Roche Diagnostics announced the launch of a new tuberculosis test for South Africa. Worldwide, South Africa is one of the countries with the highest prevalence of tuberculosis. The new kit detects different species of Mycobacterium from human sputum samples using the LightCycler® 2.0 Instrument. The diagnosis of tuberculosis in South Africa relies on smear microscopy and culture methods. Smear microscopy allows for direct detection of acid-fast bacilli (AFB) in the specimen and makes it possible to identify the most infectious patients. Although it provides rapid results and is inexpensive, it is limited by its lack of sensitivity and specificity. Based on the inherent advantages of the LightCycler® system, Roche Applied Science, South Africa has developed a LightCycler® assay that overcomes these problems. The LightCycler® Mycobacterium Detection Kit was thoroughly tested in extended analytical and clinical trials together with the National Health Laboratory Services (NHLS) (Pretoria and Kimberley Laboratories), South Africa, and at the University Hospital in Regensburg, Germany. The new test offers a number of advantages over current testing methods: it enables differentiation between Mycobacterium tuberculosis, Mycobacterium avium, and Mycobacterium kansasii in a single PCR run, and provides laboratories with reliable, accurate and objective results within hours, significantly improving patient management. Replacing the AFB smear test will significantly reduce false negative results obtained by microscopy. Use of the new test will result in fewer cultures being performed, leading to significant improvements in turnaround times for the patient. The test sequence is convenient and easy to perform; the throughput of the system suits low, medium and high throughput sample sites. "We are proud of our contribution in the battle against tuberculosis, which is really a plague in African countries. Every patient should get exactly what he needs to be cured - this is Roche"s basic idea of Personalized Healthcare. A fast, safe test result is the backbone of this concept." said Manfred Baier, Head of Roche Applied Science. Roche is currently evaluating which countries besides South Africa would also be suitable candidates for the test. Tuberculosis is one of the major causes of death from infectious diseases worldwide, killing nearly 2 million people each year. It is also the most common cause of death in developing countries for individuals infected with the human immunodeficiency virus (HIV), particularly among patients with sputum smear-negative pulmonary tuberculosis. The increase in the incidence of tuberculosis fueled by the HIV pandemic in sub-Saharan Africa has highlighted the urgent need for rapid diagnosis of tuberculosis. Roche


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009